Anthony J. Kozielski

1.0k total citations
22 papers, 800 citations indexed

About

Anthony J. Kozielski is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Anthony J. Kozielski has authored 22 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Oncology and 6 papers in Toxicology. Recurrent topics in Anthony J. Kozielski's work include Cancer therapeutics and mechanisms (17 papers), Lung Cancer Research Studies (8 papers) and Bioactive Compounds and Antitumor Agents (6 papers). Anthony J. Kozielski is often cited by papers focused on Cancer therapeutics and mechanisms (17 papers), Lung Cancer Research Studies (8 papers) and Bioactive Compounds and Antitumor Agents (6 papers). Anthony J. Kozielski collaborates with scholars based in United States, Russia and Mexico. Anthony J. Kozielski's co-authors include John S. Stehlin, Hellmuth R. Hinz, Beppino C. Giovanella, Panayotis Pantazis, John Mendoza, M Potmĕsil, R Silber, Janet Early, Jenny C. Chang and Roberto R. Rosato and has published in prestigious journals such as The Journal of Cell Biology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Anthony J. Kozielski

22 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony J. Kozielski United States 14 608 440 106 82 81 22 800
Mollie H. Wright United States 8 505 0.8× 517 1.2× 57 0.5× 15 0.2× 184 2.3× 10 801
Abdul M. Deffie Canada 9 539 0.9× 491 1.1× 50 0.5× 21 0.3× 71 0.9× 10 726
Beth Cooper United States 6 504 0.8× 122 0.3× 56 0.5× 60 0.7× 68 0.8× 6 818
Philippe Genne France 15 368 0.6× 262 0.6× 25 0.2× 23 0.3× 52 0.6× 30 632
Y.-H. Ling United States 13 333 0.5× 226 0.5× 31 0.3× 25 0.3× 44 0.5× 24 582
Sylvia Musto United States 18 466 0.8× 328 0.7× 24 0.2× 92 1.1× 36 0.4× 32 943
Xingzhi Tan United States 13 486 0.8× 363 0.8× 21 0.2× 47 0.6× 100 1.2× 20 815
Kinsie E. Arnst United States 11 363 0.6× 218 0.5× 38 0.4× 46 0.6× 31 0.4× 15 751
Aurelio Di Marco Italy 17 468 0.8× 407 0.9× 46 0.4× 105 1.3× 47 0.6× 33 924
Stéphane Olland United States 11 524 0.9× 175 0.4× 71 0.7× 42 0.5× 15 0.2× 16 761

Countries citing papers authored by Anthony J. Kozielski

Since Specialization
Citations

This map shows the geographic impact of Anthony J. Kozielski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Kozielski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Kozielski more than expected).

Fields of papers citing papers by Anthony J. Kozielski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony J. Kozielski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Kozielski. The network helps show where Anthony J. Kozielski may publish in the future.

Co-authorship network of co-authors of Anthony J. Kozielski

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Kozielski. A scholar is included among the top collaborators of Anthony J. Kozielski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Kozielski. Anthony J. Kozielski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozielski, Anthony J., Wei Qian, Alfred A. Chan, et al.. (2022). Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6. npj Breast Cancer. 8(1). 30–30. 23 indexed citations
2.
Mukherjee, Madhumita, Yannis Kalaidzidis, Anthony J. Kozielski, et al.. (2019). SNX27–retromer assembly recycles MT1-MMP to invadopodia and promotes breast cancer metastasis. The Journal of Cell Biology. 219(1). 36 indexed citations
3.
Dávila‐González, Daniel, Dong Soon Choi, Roberto R. Rosato, et al.. (2018). Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer. Clinical Cancer Research. 24(5). 1152–1162. 68 indexed citations
4.
Rosato, Roberto R., Daniel Dávila‐González, Dong Soon Choi, et al.. (2018). Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models. Breast Cancer Research. 20(1). 108–108. 81 indexed citations
5.
Mendoza, John, Anthony J. Kozielski, Xing Liu, et al.. (2012). Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice. Anti-Cancer Agents in Medicinal Chemistry. 12(7). 818–828. 3 indexed citations
6.
7.
Kozielski, Anthony J., et al.. (2009). Crystalline Camptothecin-20(S)-O-Propionate Hydrate:A Novel Anticancer Agent with Strong Activity against 19 Human Tumor Xenografts. Cancer Research. 69(11). 4742–4749. 13 indexed citations
8.
Pantazis, Panayotis, John Mendoza, Janet Early, et al.. (2003). Structure-activity relationship of alkyl 9-nitrocamptothecin esters.. PubMed. 24(2). 109–19. 6 indexed citations
9.
Giovanella, Beppino C., et al.. (2002). Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan). International Journal of Oncology. 20(1). 81–8. 38 indexed citations
10.
Mendoza, John, Janet Early, Anthony J. Kozielski, et al.. (2000). Structure‐Activity Relationship of Alkyl Camptothecin Esters. Annals of the New York Academy of Sciences. 922(1). 122–135. 17 indexed citations
11.
12.
Harris, Nick, et al.. (1998). Alkyl Esters of Camptothecin and 9-Nitrocamptothecin:  Synthesis, in Vitro Pharmacokinetics, Toxicity, and Antitumor Activity. Journal of Medicinal Chemistry. 41(1). 31–37. 88 indexed citations
13.
Ahmed, Amany A.E., Sam Jacob, Beppino C. Giovanella, et al.. (1996). Influence of route of administration on [ 3 H]-camptothecin distribution and tumor uptake in CASE-bearing nude mice: whole-body autoradiographic studies. Cancer Chemotherapy and Pharmacology. 39(1-2). 122–130. 9 indexed citations
14.
Potmĕsil, M, Leonard Liebes, S Sekiya, et al.. (1995). Pharmacodynamics/pharmacokinetics of intragastric camptothecin analogs in a human-cancer xenograft model. 36. 445. 4 indexed citations
15.
Mendoza, John, et al.. (1995). Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action. Leukemia Research. 19(1). 43–55. 9 indexed citations
16.
Pantazis, Panayotis, et al.. (1994). Therapeutic efficacy of camptothecin derivatives against human malignant melanoma xenografts. Melanoma Research. 4(1). 5–10. 31 indexed citations
17.
Pantazis, Panayotis, John Mendoza, Janet Early, et al.. (1993). 9‐nitro‐camptothecin delays growth of U‐937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia linesin vitro. European Journal Of Haematology. 50(2). 81–89. 18 indexed citations
18.
Pantazis, Panayotis, Anthony J. Kozielski, John Mendoza, et al.. (1993). Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non‐tumorigenic and tumorigenic cells in vitro. International Journal of Cancer. 53(5). 863–871. 49 indexed citations
19.
Pantazis, Panayotis, et al.. (1992). Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins.. PubMed. 52(14). 3980–7. 77 indexed citations
20.
Hinz, Hellmuth R., et al.. (1991). Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin.. PubMed. 51(11). 3052–5. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mollie H. Wright Breakdown of academic impact, for papers by Abdul M. Deffie Breakdown of academic impact, for papers by Beth Cooper Breakdown of academic impact, for papers by Philippe Genne Breakdown of academic impact, for papers by Y.-H. Ling Breakdown of academic impact, for papers by Sylvia Musto Breakdown of academic impact, for papers by Xingzhi Tan Breakdown of academic impact, for papers by Kinsie E. Arnst Breakdown of academic impact, for papers by Aurelio Di Marco Breakdown of academic impact, for papers by Stéphane Olland
Rankless by CCL
2026